Alexandria Real Estate Equities is a real estate investment trust that owns and operates laboratory and office space for the life science and technology industries. Its campuses are concentrated in research clusters across the United States, where it leases space to pharmaceutical companies, biotechnology firms and other research organisations. The company is based in Pasadena, California, and its business centres on developing and managing collaborative environments for scientific tenants.
Alexandria Real Estate Equities, Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code A1RE34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1226 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendWeak
26/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-19.3%
From 52-week high-49.5%
MomentumWeak
15/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-19.3%
6-month return-14.4%
12-month, skipping last month-27.5%
Stability (higher is calmer)Weak
25/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)52.5%
Worst drawdown, 1 year (smaller is calmer)-51.7%
LiquidityWeak
36/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.01M BRL
Zero-volume days11.7%
IncomeStrong
71/100
Dividend is high and has been paid regularly.
See the numbers →
Dividend yield5.1%
Years with dividends6
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 48.72 – 102.15Daily closes, split-adjusted
Signals
50-day average63.12
200-day average63.52
Golden/death cross (60d)Death, 2 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.46
Technical summary
Daily
Bearish
4 bullish · 0 neutral · 12 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
55.44
Bearish
EMA 10
55.33
Bearish
SMA 20
59.97
Bearish
EMA 20
58.39
Bearish
SMA 50
63.12
Bearish
EMA 50
61.63
Bearish
SMA 100
63.90
Bearish
EMA 100
62.92
Bearish
SMA 200
63.52
Bearish
EMA 200
67.27
Bearish
Oscillators (daily)
RSI (14)
23.74
Bullish
MACD (12, 26)
-3.43
Bearish
Momentum (12)
-17.39
Bearish
Stochastic %K (14)
4.34
Bullish
Williams %R (14)
-95.66
Bullish
CCI (20)
-127.8
Bullish
Pivot points (classic, last session)
S3
50.33
S2
50.52
S1
50.88
Pivot
51.07
R1
51.43
R2
51.62
R3
51.98
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
2.60 USD
Yield on today's price
5.07%
Frequency
Quarterly
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
29 Sep 2026
0.6498
29 Jun 2026
0.6422
30 Mar 2026
0.6300
29 Dec 2025
0.6778
29 Sep 2025
1.2554
27 Jun 2025
1.2870
28 Mar 2025
1.3583
27 Dec 2024
1.3933
27 Sep 2024
1.2909
27 Jun 2024
1.2346
27 Mar 2024
1.1697
27 Dec 2023
1.0898
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
